Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?

Fingolimod 0.5-mg once-daily is an approved therapy for patients with relapsing–remitting multiple sclerosis (MS). Several pivotal and real-world studies have demonstrated that fingolimod is associated with the development of macular edema (ME). Herein, we present a case of a diabetic MS patient who...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Sci
Autori principali: Pul, Refik, Osmanovic, Alma, Schmalstieg, Holger, Pielen, Amelie, Pars, Kaweh, Schwenkenbecher, Philipp, Sühs, Kurt Wolfram, Yildiz, Özlem, Frank, Benedikt, Stangel, Martin, Skripuletz, Thomas
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2016
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5187906/
https://ncbi.nlm.nih.gov/pubmed/27983657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17122106
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi